The Enforcement Directorate Director, Rahul Navin, has been given a one-year extension, as approved by the Appointments Committee of the Cabinet. Mr. Navin’s tenure as the ED chief has been extended ...

Navin Fluorine has reported a strong performance for the first quarter of FY27, with consolidated revenue rising 44% year-on-year and 11% sequentially to Rs. 1,045.1 crore, driven by broad-based ...

USA ‌international Akhilesh Reddy has ⁠been ⁠suspended for eight years after being found guilty of match-fixing, the International Cricket Council (ICC) says. Reddy was ⁠charged in November with ...

Aug 3 (Reuters) - U.S. international Akhilesh Reddy has been suspended for eight years after being found guilty ‌of match-fixing charges, the International Cricket Council (ICC) said on Monday. Reddy ...

Navin Fluorine International Ltd. entered into a strategic partnership with the Defence Research and Development Organisation (DRDO) to develop indigenous manufacturing technology for sodium ...

The Emirates Cricket Board (ECB) had appointed the ICC as the designated anti-corruption official (DACO), and the ICC's anti-corruption tribunal has now found Reddy guilty on all three counts. The ban ...

Hyderabad: Dr Reddy’s Laboratories has secured the US Food and Drug Administration (FDA) approval to market its rituximab biosimilar in the country. Under a commercialization agreement, Fresenius Kabi ...

Navin Fluorine International Limited (NFIL) has signed a significant agreement with India’s Defence Research and Development Organisation (DRDO) for the project ‘Indigenous Manufacturing of Sodium ...

For someone whose office has a view of a carnival, Lonny Warner is decidedly unwhimsical. The CEO of Reddy Ice, the largest producer of packaged ice in North America, Warner is tall and broad in ...

Dr. Reddy’s Laboratories Ltd. cut the first-year manufacturing target for its generic Ozempic drug as it paused commercial production until at least October after finding an unknown impurity in a key ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the part of the drugmaker can take a toll. Case in point, Dr. Reddy’s share price ...